Benjamin J. Zeskind, President and CEO, 10% Owner at Immuneering Corp (IMRX), bought 51,197 shares at $15.00 ($31K) on 2021-08-03, disclosed to the SEC on 2021-08-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 49,099 | $0 | 0.0% |
| 2 | $15.00 | 2,098 | $31K | 100.0% |
| Total | $0.61 avg | 51,197 | $31K | 100% |
| Filing → |
| IMRX | BUY | 2025-06-20 | $50K | — | Filing → |
| IMRX | BUY | 2024-03-19 | $55K | — | Filing → |
| IMRX | BUY | 2022-03-24 | $24K | — | Filing → |